The reference for “38” was erroneously written as “Konieczna-Wolska K, Caratis F, Opiełka M, Biernacki K, Urbanowicz K, Klimaszewska J, et al. Accelerated remyelination and immune modulation by the EBI2 agonist 7a,25-dihydroxycholesterol analogue in the cuprizone model. BioMed Pharmacother. (2024) 181(3):5173–88. doi: 10.1016/ J.BIOPHA.2024.117653”. It should be “Konieczna-Wolska K, Caratis F, Opiełka M, Biernacki K, Urbanowicz K, Klimaszewska J, Pobiarzyn P, Krajewski O, Demkowicz S, Smoleński RT, Karaszewski B, Seuwen K, Rutkowska A. Accelerated remyelination and immune modulation by the EBI2 agonist 7α,25-dihydroxycholesterol analogue in the cuprizone model. Biomed Pharmacother. 2024 Dec;181:117653. doi: 10.1016/j.biopha.2024.117653”.
The original version of this article has been updated.
The reference for “6” was erroneously written as “Kanduc D, Shoenfeld Y. From anti-EBV immune responses to the EBV diseasome via cross-reactivity. (2020) 7(2):51–63. doi: 10.1055/S-0040-1715641”. It should be “Kanduc D, Shoenfeld Y. From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity. Glob Med Genet. 2020 Aug;7(2):51-63. doi: 10.1055/s-0040-1715641”.
The original version of this article has been updated.
Footnotes
Approved by: Frontiers Editorial Office , Frontiers Media SA, Switzerland
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.